131 related articles for article (PubMed ID: 1562975)
1. K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men.
Konishi N; Enomoto T; Buzard G; Ohshima M; Ward JM; Rice JM
Cancer; 1992 May; 69(9):2293-9. PubMed ID: 1562975
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ras activation in prostate carcinoma in Japanese and American men.
Konishi N; Hiasa Y; Tsuzuki T; Tao M; Enomoto T; Miller GJ
Prostate; 1997 Jan; 30(1):53-7. PubMed ID: 9018336
[TBL] [Abstract][Full Text] [Related]
3. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
[TBL] [Abstract][Full Text] [Related]
4. Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas.
Pergolizzi RG; Kreis W; Rottach C; Susin M; Broome JD
Cancer Invest; 1993; 11(1):25-32. PubMed ID: 7678540
[TBL] [Abstract][Full Text] [Related]
5. Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patients.
Song MM; Nio Y; Dong M; Tamura K; Furuse K; Tian YL; He SG; Shen K
J Surg Oncol; 2000 Nov; 75(3):176-85. PubMed ID: 11088049
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
[TBL] [Abstract][Full Text] [Related]
7. K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma.
Li S; Rosell R; Urban A; Font A; Ariza A; Armengol P; Abad A; Navas JJ; Monzo M
Lung Cancer; 1994 Jul; 11(1-2):19-27. PubMed ID: 8081702
[TBL] [Abstract][Full Text] [Related]
8. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
9. K-ras activation in gastric epithelial tumors in Japanese.
Miki H; Ohmori M; Perantoni AO; Enomoto T
Cancer Lett; 1991 Jun; 58(1-2):107-13. PubMed ID: 2049776
[TBL] [Abstract][Full Text] [Related]
10. Activation of the c-Ki-ras oncogene in aflatoxin B1-induced hepatocellular carcinoma and adenoma in the rat: detection by denaturing gradient gel electrophoresis.
Soman NR; Wogan GN
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):2045-9. PubMed ID: 8446626
[TBL] [Abstract][Full Text] [Related]
11. c-Ki-ras point mutations in ductectatic-type mucinous cystic neoplasms of the pancreas.
Yanagisawa A; Kato Y; Ohtake K; Kitagawa T; Ohashi K; Hori M; Takagi K; Sugano H
Jpn J Cancer Res; 1991 Oct; 82(10):1057-60. PubMed ID: 1955373
[TBL] [Abstract][Full Text] [Related]
12. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.
Enomoto T; Weghorst CM; Inoue M; Tanizawa O; Rice JM
Am J Pathol; 1991 Oct; 139(4):777-85. PubMed ID: 1656759
[TBL] [Abstract][Full Text] [Related]
13. H-ras oncogene point mutations in arthritic synovium.
Roivainen A; Jalava J; Pirilä L; Yli-Jama T; Tiusanen H; Toivanen P
Arthritis Rheum; 1997 Sep; 40(9):1636-43. PubMed ID: 9324018
[TBL] [Abstract][Full Text] [Related]
14. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado.
Enomoto T; Fujita M; Inoue M; Nomura T; Shroyer KR
Am J Clin Pathol; 1995 Feb; 103(2):224-30. PubMed ID: 7856567
[TBL] [Abstract][Full Text] [Related]
16. GGT to GTT transversions in codon 12 of the K-ras oncogene in rat renal sarcomas induced with nickel subsulfide or nickel subsulfide/iron are consistent with oxidative damage to DNA.
Higinbotham KG; Rice JM; Diwan BA; Kasprzak KS; Reed CD; Perantoni AO
Cancer Res; 1992 Sep; 52(17):4747-51. PubMed ID: 1511440
[TBL] [Abstract][Full Text] [Related]
17. International comparison on ras gene mutations in latent prostate carcinoma.
Watanabe M; Shiraishi T; Yatani R; Nomura AM; Stemmermann GN
Int J Cancer; 1994 Jul; 58(2):174-8. PubMed ID: 8026877
[TBL] [Abstract][Full Text] [Related]
18. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas.
Anwar K; Nakakuki K; Shiraishi T; Naiki H; Yatani R; Inuzuka M
Cancer Res; 1992 Nov; 52(21):5991-6. PubMed ID: 1382850
[TBL] [Abstract][Full Text] [Related]
19. Detection of c-ras gene mutation and expression of p21 protein in dysplasias and carcinomas complicating ulcerative colitis.
Tsuda T; Mochizuki M; Wakasa H
J Gastroenterol; 1995 Nov; 30 Suppl 8():30-2. PubMed ID: 8563883
[TBL] [Abstract][Full Text] [Related]
20. Infrequent RAS oncogene mutations in human prostate cancer.
Moul JW; Friedrichs PA; Lance RS; Theune SM; Chang EH
Prostate; 1992; 20(4):327-38. PubMed ID: 1608859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
